CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma

被引：64
|
作者：
Madduri, Deepu
Berdeja, Jesus G.
Usmani, Saad Z.
Jakubowiak, Andrzej
Agha, Mounzer
Cohen, Adam D.
Stewart, A. Keith
Hari, Parameswaran
Htut, Myo
O'Donnell, Elizabeth
Munshi, Nikhil C.
Avigan, David E.
Deol, Abhinav
Lesokhin, Alexander M.
Singh, Indrajeet
Zudaire, Enrique
Yeh, Tzu-Min
Allred, Alicia J.
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Deraedt, William
Zhuang, Sen Hong
Infante, Jeffrey R.
Geng, Dong
Wu, Xiaoling
Carrasco, Marlene J.
Akram, Muhammad
Hossain, Farah
Rizvi, Syed
Fan, Frank
Jagannath, Sundar
Lin, Yi
Martin, Thomas, III
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136307
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma
    Zhao, Wan-Hong
    Liu, Jie
    Wang, Bai-Yan
    Chen, Yin-Xia
    Cao, Xing-Mei
    Yang, Yun
    Zhang, Yi-Lin
    Wang, Fang-Xia
    Zhang, Peng-Yu
    Lei, Bo
    Gu, Liu-Fang
    Wang, Jian-Li
    Yang, Nan
    Zhang, Ru
    Zhang, Hui
    Shen, Ying
    Bai, Ju
    Xu, Yan
    Wang, Xu-Geng
    Zhang, Rui-Li
    Wei, Li-Li
    Li, Zong-Fang
    Li, Zhen-Zhen
    Geng, Yan
    He, Qian
    Zhuang, Qiu-Chuan
    Fan, Frank Xiao-Hu
    He, Ai-Li
    Zhang, Wang-Gang
    BLOOD, 2018, 132
  • [32] Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma
    Josyula, Srirama
    Pont, Margot J.
    Dasgupta, Sayan
    Song, Xiaoling
    Thomas, Sushma
    Pepper, Gregory
    Keane-Candib, Jacob
    Stevens-Ayers, Terry L.
    Ochs, Hans D.
    Boeckh, Michael J.
    Riddell, Stanley R.
    Cowan, Andrew J.
    Krantz, Elizabeth M.
    Green, Damian J.
    Hill, Joshua A.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (06): : 304.e1 - 304.e9
  • [33] Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma
    Mohan, Meera
    Nagavally, Sneha
    Dhakal, Binod
    Radhakrishnan, Sabarinath Venniyil
    Chhabra, Saurabh
    D'Souza, Anita
    Hari, Parameswaran
    BLOOD ADVANCES, 2022, 6 (08) : 2466 - 2470
  • [34] Efficacy and Safety of Ciltacabtagene Autoleucel (Cilta-cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Lenalidomide-Refractory Patients with Progressive Multiple Myeloma after 1-3 Prior Lines of Therapy: Updated Results from CARTITUDE-2
    Cohen, Yael C.
    Cohen, Adam D.
    Delforge, Michel
    Hillengass, Jens
    Goldschmidt, Hartmut
    Weisel, Katja
    Raab, Marc-Steffen
    Scheid, Christof
    Schecter, Jordan M.
    De Braganca, Kevin C.
    Varsos, Helen
    Yeh, Tzu-min
    Wang, Liwei
    Vogel, Martin
    Corsale, Christina
    Akram, Muhammad
    Pacaud, Lida
    Nesheiwat, Tonia
    Agha, Mounzer
    Einsele, Hermann
    BLOOD, 2021, 138 : 3866 - +
  • [35] B-Cell Maturation Antigen-Directed Immunotherapies for the Treatment of Relapsed/Refractory Multiple Myeloma: A Review of the Literature and Implications for Clinical Practice
    Peery, Matthew R.
    Hill, Hailey
    Sharps, Amanda
    Zaver, Aarti
    Moore, Donald C.
    ANNALS OF PHARMACOTHERAPY, 2024,
  • [36] Multiple Myeloma, Targeting B-Cell Maturation Antigen With Chimeric Antigen Receptor T-Cells
    Shah, Urvi A.
    Smith, Eric L.
    CANCER JOURNAL, 2019, 25 (03): : 208 - 216
  • [37] Biomarker Correlates of Response to Ciltacabtagene Autoleucel in Patients with Relapsed or Refractory Multiple Myeloma from CARTITUDE-1, a Phase 1b/2 Open- Label Study, at the ∼3 Year Follow-up
    de Oca, Rocio Montes
    Gu, Junchen
    Zhao, Hao
    Zelinsky, Kathy
    Wu, Dianna
    Davis, Cuc
    Patel, Jaymala
    Foulk, Brad
    Boominathan, Rengasamy
    Lau, Onsay
    Smirnov, Denis
    Lin, Yi
    Jagannath, Sundar
    Cohen, Adam D.
    Haddish-Berhane, Nahor
    Xu, Jean
    Madduri, Deepu
    Stevens, An-Sofie
    Jackson, Carolyn Chang
    Schecter, Jordan M.
    Banerjee, Arnob
    Geng, Dong
    Zhu, Jieqing
    Xu, Sifan
    Zudaire, Enrique
    BLOOD, 2023, 142
  • [38] Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label study
    Martin, Thomas
    Lin, Yi
    Agha, Mounzer
    Cohen, Adam D.
    Htut, Myo
    Stewart, A. Keith
    Hari, Parameswaran
    Berdeja, Jesus G.
    Usmani, Saad Z.
    Yeh, Tzu-Min
    Olyslager, Yunsi
    Goldberg, Jenna D.
    Schecter, Jordan M.
    Madduri, Deepu
    Jackson, Carolyn C.
    Deraedt, William
    Gries, Katharine S.
    Fastenau, John M.
    Trudeau, Jeremiah J.
    Akram, Muhammad
    Pacaud, Lida
    Jakubowiak, Andrzej
    Jagannath, Sundar
    LANCET HAEMATOLOGY, 2022, 9 (12): : E897 - E905
  • [39] Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
    Timmers, Marijke
    Roex, Gils
    Wang, Yuedi
    Campillo-Davo, Diana
    Van Tendeloo, Viggo F., I
    Chu, Yiwei
    Berneman, Zwi N.
    Luo, Feifei
    Van Acker, Heleen H.
    Anguille, Sebastien
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [40] Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma
    Salem, Dalia A.
    Maric, Irina
    Yuan, Constance M.
    Liewehr, David J.
    Venzon, David J.
    Kochenderfer, James
    Stetler-Stevenson, Maryalice
    LEUKEMIA RESEARCH, 2018, 71 : 106 - 111
12345